Optimal tumor sampling for immunostaining of biomarkers in breast carcinoma

INTRODUCTION: Biomarkers, such as Estrogen Receptor, are used to determine therapy and prognosis in breast carcinoma. Immunostaining assays of biomarker expression have a high rate of inaccuracy; for example, estimates are as high as 20% for Estrogen Receptor. Biomarkers have been shown to be hetero...

Descripción completa

Detalles Bibliográficos
Autores principales: Tolles, Juliana, Bai, Yalai, Baquero, Maria, Harris, Lyndsay N, Rimm, David L, Molinaro, Annette M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218938/
https://www.ncbi.nlm.nih.gov/pubmed/21592345
http://dx.doi.org/10.1186/bcr2882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218938/
https://www.ncbi.nlm.nih.gov/pubmed/21592345
http://dx.doi.org/10.1186/bcr2882

Ejemplares similares